STING activation counters glioblastoma by vascular alteration and immune surveillance
出版年份 2023 全文链接
标题
STING activation counters glioblastoma by vascular alteration and immune surveillance
作者
关键词
-
出版物
CANCER LETTERS
Volume -, Issue -, Pages 216480
出版商
Elsevier BV
发表日期
2023-11-05
DOI
10.1016/j.canlet.2023.216480
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- STING agonism turns human T cells into interferon‐producing cells but impedes their functionality
- (2023) Niklas Kuhl et al. EMBO REPORTS
- Reelin cells and sex‐dependent synaptopathology in autism following postnatal immune activation
- (2022) Maryam Ardalan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibition
- (2022) Justin T. Low et al. CANCER CELL
- STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models
- (2022) Gilles Berger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative Analysis of Stk11/Lkb1 versus Pten Deficiency in Lung Adenocarcinoma Induced by CRISPR/Cas9
- (2021) Martin F. Berthelsen et al. Cancers
- ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
- (2021) Su Chul Jang et al. Communications Biology
- STING Agonists as Cancer Therapeutics
- (2021) Afsaneh Amouzegar et al. Cancers
- Preoperative Metastatic Brain Tumor-Associated Intracerebral Hemorrhage Is Associated With Dismal Prognosis
- (2021) Motaz Hamed et al. Frontiers in Oncology
- Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study
- (2021) Hussein A Tawbi et al. LANCET ONCOLOGY
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses
- (2020) Tania Løve Aaes et al. CELL DEATH AND DIFFERENTIATION
- Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition
- (2019) Aida Karachi et al. NEURO-ONCOLOGY
- Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
- (2019) Lucio Crinò et al. LUNG CANCER
- Adverse Event Profiles of Anti-CTLA-4 and Anti-PD-1 Monoclonal Antibodies Alone or in Combination: Analysis of Spontaneous Reports Submitted to FAERS
- (2019) Huan-huan Ji et al. CLINICAL DRUG INVESTIGATION
- Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
- (2019) Edward B. Garon et al. JOURNAL OF CLINICAL ONCOLOGY
- STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
- (2019) Hannah Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- STING: a master regulator in the cancer-immunity cycle
- (2019) Yuanyuan Zhu et al. Molecular Cancer
- The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma
- (2019) Martin K. Thomsen et al. ONCOGENE
- STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice
- (2018) Morten K. Skouboe et al. PLoS Pathogens
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response
- (2018) Erin D. Lucas et al. JOURNAL OF IMMUNOLOGY
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
- (2018) Hussein A. Tawbi et al. NEW ENGLAND JOURNAL OF MEDICINE
- AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
- (2017) Ryan D Chow et al. NATURE NEUROSCIENCE
- CNS cancer: Glioblastoma subtypes revisited
- (2017) Peter Sidaway Nature Reviews Clinical Oncology
- Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
- (2017) Jann N Sarkaria et al. NEURO-ONCOLOGY
- Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
- (2017) Antonio Omuro et al. NEURO-ONCOLOGY
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- White matter biomarkers from fast protocols using axially symmetric diffusion kurtosis imaging
- (2017) Brian Hansen et al. NMR IN BIOMEDICINE
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
- (2016) Anna Rita Cantelmo et al. CANCER CELL
- STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
- (2015) Olivier Demaria et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The STING pathway and the T cell-inflamed tumor microenvironment
- (2015) Seng-Ryong Woo et al. TRENDS IN IMMUNOLOGY
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
- (2015) D. A. Reardon et al. Cancer Immunology Research
- Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs
- (2014) Lingyin Li et al. Nature Chemical Biology
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
- (2013) Jing Zeng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Diffusion-Weighted MRI and Quantitative Biophysical Modeling of Hippocampal Neurite Loss in Chronic Stress
- (2011) Peter Vestergaard-Poulsen et al. PLoS One
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Development of a novel mouse glioma model using lentiviral vectors
- (2009) Tomotoshi Marumoto et al. NATURE MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started